Stay updated on AFM24 + Atezolizumab in EGFR+ Cancers Clinical Trial

Sign up to get notified when there's something new on the AFM24 + Atezolizumab in EGFR+ Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AFM24 + Atezolizumab in EGFR+ Cancers Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Major update: new operating-status notice and v3.2.0 release replaces v3.1.0; core content about status and transaction processing updated.
    Difference
    3%
    Check dated 2025-10-05T10:15:13.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T03:16:29.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.0.2, replacing Revision: v3.0.1. The Back to Top element has been removed.
    Difference
    0.2%
    Check dated 2025-09-13T17:36:08.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-06T15:14:20.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of specific facility names and locations in South Korea and Poland, as well as new content related to drug administration and therapy. Notably, the version has been updated from v2.16.12 to v3.0.0.
    Difference
    8%
    Check dated 2025-08-30T11:49:16.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    The study assessing AFM24 in combination with Atezolizumab has been terminated due to financial issues, and several key dates and metrics related to the study have been updated or removed.
    Difference
    49%
    Check dated 2025-08-23T07:52:32.000Z thumbnail image

Stay in the know with updates to AFM24 + Atezolizumab in EGFR+ Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AFM24 + Atezolizumab in EGFR+ Cancers Clinical Trial page.